Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (3856)	12/17/1997 11:00:00 PM
From: Dermot Dunne	Read Replies (1) \| Respond to of 23519

who is Gangol, and is he still with the company? vivus.com lists the officers of the company: Paul C. Doherty, Ph.D. Vice President, Research Julian Gangolli Vice President, Marketing Neil Gesundheit, M.D. Vice President, Clinical Carol D. Karp Vice President, Regulatory Affairs Terry M. Nida Vice President, Europe John Richard Vice President, Corporate Development Clair W. Sater Vice President, International Development William L. Smith Vice President, Research & Development David C. Yntema Vice President, Finance and Chief Financial Officer Dermot

To: LoLoLoLita who wrote (3856)	12/17/1997 11:56:00 PM
From: blankmind	Read Replies (3) \| Respond to of 23519

David, - There you go again. -- Where's the proff that any insider sold anything in November? -- You sound like you missed the run up in VVUS. And now you're trying to bad-mouth the stock. Otherwise, why don't you own any shares? Out.